Dickinson Andrew D sold GILD
February 18, 2025 · Form 4 insider transaction
Dickinson Andrew D sold 2,500 shares of Gilead Sciences, Inc. at $104.09 per share, a transaction worth $260.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$104.09
Total value
$260.2K
InsiderDickinson Andrew D
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 18, 2025
Filing dateFebruary 19, 2025
Shares owned after169,061
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.; Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.